Is corifollitropin alfa effective in controlled ovarian stimulation among all poor ovarian responders? A retrospective comparative study.


Journal

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
ISSN: 1473-0766
Titre abrégé: Gynecol Endocrinol
Pays: England
ID NLM: 8807913

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 14 5 2019
medline: 13 8 2020
entrez: 14 5 2019
Statut: ppublish

Résumé

Several studies have compared the effectiveness of corifollitropin alfa versus daily gonadotropins in poor ovarian responders (PORs) undergoing controlled ovarian stimulation (COS), showing conflicting results in terms of IVF outcomes. Given the heterogeneity of patients included in the classification of POR according to 'Bologna criteria', the aim of this study was to evaluate the impact of corifollitropin alfa in two different categories of POR distinguished according to patients' antral follicle count (AFC). We retrospectively evaluated 104 infertile POR, split into two groups according to AFC (Group A ≤ 5; Group B > 5) and subgroups according to the ovarian stimulation regimen (corifollitropin alfa plus daily gonadotropins (Subgroup 1) versus daily gonadotropins alone (Subgroup 2)). Outcome measures were total oocytes, MII oocytes, total embryos, follicular output rate (FORT), implantation rate (IR), clinical pregnancy rate (CPR), miscarriage rate (MR), and live birth rate (LBR). Subgroup A1 experienced a lower number of total oocytes, MII oocytes, total embryos, and FORT (

Identifiants

pubmed: 31081709
doi: 10.1080/09513590.2019.1613360
doi:

Substances chimiques

Follicle Stimulating Hormone, Human 0
follicle stimulating hormone, human, with HCG C-terminal peptide 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

894-898

Auteurs

A Andrisani (A)

Department of Women's and Children's Health, University of Padua, Salus Pueri, Padua, Italy.

L Marin (L)

Department of Women's and Children's Health, University of Padua, Salus Pueri, Padua, Italy.

E Ragazzi (E)

Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.

G Donà (G)

Department of Molecular Medicine, Biological Chemistry, University of Padua, Padua, Italy.

L Bordin (L)

Department of Molecular Medicine, Biological Chemistry, University of Padua, Padua, Italy.

F Dessole (F)

Department of Surgical, Microsurgical and Medical Sciences, Gynecologic and Obstetric Clinic, University of Sassari, Sassari, Italy.

D Armanini (D)

Department of Medicine (DIMED), Endocrinology Unit, University of Padua, Padua, Italy.

F Esposito (F)

Department of Women's and Children's Health, University of Padua, Salus Pueri, Padua, Italy.

A Vitagliano (A)

Department of Women's and Children's Health, University of Padua, Salus Pueri, Padua, Italy.

C Sabbadin (C)

Department of Medicine (DIMED), Endocrinology Unit, University of Padua, Padua, Italy.

G Ambrosini (G)

Department of Women's and Children's Health, University of Padua, Salus Pueri, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH